U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

With Trump in office and Republicans controlling Congress, it’s time for the president to continue work he started and ...

America is about to take the red pill. This nation is about to find out some ugly truths about vaccines in general — the deadly COVID vaccine in particular — and the crimes of Dr. Anthony Fauci and ...

Patients in the United States pay the highest prescription drug prices in the world — on average four times what people in ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Patients in the United States pay the highest prescription drug prices in the world — on average four times what people in other developed countries pay for the exact same brand-name medications.

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

Patients in the United States pay the highest prescription drug prices in the world — on average four times what people in other developed countries pay for the exact same brand-name medications.